CAMTEK LTD.
(Translation of
Registrants Name into English)
Ramat Gavriel
Industrial Zone
P.O. Box 544
Migdal Haemek 23150
ISRAEL
(Address of Principal Corporate
Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities and Exchange Act of 1934.
Yes o No x
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CAMTEK LTD. (Registrant) BY: /S/ MOSHE AMIT Moshe Amit, Executive Vice President and Chief Financial Officer |
Dated: January 10, 2005
2
January 10, 2005
CAMTEK: | IR/PR ISRAEL | IR INTERNATIONAL |
Moshe Amit, CFO | Financial Communication | Kenny Green |
Tel: +972-4-604-8308 | Noam Yellin | Gelbart-Kahana International |
Fax: +972-4-604 8300 | Tel: +972 3 6954333 | Tel: (US) 1 646 201 9246 |
Mobile: +972-5-469-4902 | Fax: +972 544 246720 | Freephone: (US) 1 866 704 6710 |
mosheamit@camtek.co.il | kenny@gk-biz.com | |
ehud@gk-biz.com |
MIGDAL HAEMEK, Israel January 10, 2005 Camtek Ltd. (NASDAQ: CAMT), announced that Priortech Ltd., its parent company, raised today NIS 53.5 million (approximately $12.2 million) through a private offering to a limited number of Israeli institutional investors, of 2-5year non-traded debentures convertible into Camtek shares held by Priortech at a conversion price of $5.50 per share. Priortech will be able to force conversion of these debentures if the closing price of Camteks shares is over $8.25 for 30 consecutive trading days, or to redeem the debentures at any time at a premium. The transaction also includes options to purchase 791,800 additional Camtek shares held by Priortech at an exercise price of $6.25 per share, with a four year term.
Priortech Ltd., whose shares are traded on the Tel Aviv Stock Exchange, currently holds approximately 77.8% of Camteks outstanding shares. If all of the debentures and options included in the transaction are converted into, or exercised for, Camtek shares, Priortechs holdings will be reduced to 66.6%, and it will receive additional proceeds of approximately $4.95 million from the exercise of the options. The investors hold a lien on a portion of Priortechs Camtek shares reflecting 150% of the principle amount of their debentures. It is expected that Camtek will file a registration statement with the U.S. Securities and Exchange Commission permitting the resale to the public of any Camtek shares acquired by the investors as a result of the conversion of the debentures or exercise of the options.
Rafi Amit, Camteks CEO, commented: As we previously announced, while this is essentially a Priortech deal, we believe that Priortechs plans to potentially reduce its holdings in Camtek will be of benefit to Camtek. We believe that the increase in the liquidity of Camteks shares that may result from the conversion of the debentures and the exercise of the options, through the shift of up to 10.5% of Camteks equity from Priortech into the hands of Israeli institutional investors and ultimately into the hands of the broader public, will benefit both Camtek and its shareholders.
ABOUT CAMTEK LTD.
With headquarters in Migdal
HaEmek Israel, Camtek Ltd., designs, develops, manufactures, and markets automatic
optical inspection systems and related products. Camteks automatic inspection
systems are used to enhance both production processes and yield for manufacturers in the
printed circuit board industry, the high density interconnect substrate industry and the
semiconductor manufacturing and packaging industry. This press release is available at
www.camtek.co.il.
This press release may contain projections or other forward-looking statements regarding future events or the future performance of the Company. These statements are only predictions and may change as time passes. We do not assume any obligation to update that information. Actual events or results may differ materially from those projected, including as a result of changing industry and market trends, reduced demand for our products, the timely development of our new products and their adoption by the market, increased competition in the industry and price reductions, as well as due to risks identified in the documents filed by the Company with the SEC. In particular, there can be no assurance that the investors will convert their debentures into Camtek shares or exercise their options to acquire Camtek shares from Priortech.
3